The store will not work correctly when cookies are disabled.
(4-Methylphenyl)(3,9-diazaspiro[5.5]undecan-3-yl)methanone
ID: ALA5204910
PubChem CID: 97407968
Max Phase: Preclinical
Molecular Formula: C17H24N2O
Molecular Weight: 272.39
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(C(=O)N2CCC3(CCNCC3)CC2)cc1
Standard InChI: InChI=1S/C17H24N2O/c1-14-2-4-15(5-3-14)16(20)19-12-8-17(9-13-19)6-10-18-11-7-17/h2-5,18H,6-13H2,1H3
Standard InChI Key: OJPBMIZUSSIFGI-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
2.3686 -9.0745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0836 -9.4861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7956 -9.0785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7989 -8.2536 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0839 -7.8379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3657 -8.2513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9428 -9.0745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9428 -9.9018 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6573 -10.3092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3718 -9.9018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6573 -8.6547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5127 -7.8398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5149 -7.0125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2230 -8.2514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2213 -9.0756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9332 -9.4874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6471 -9.0760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6448 -8.2487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9324 -7.8407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3603 -9.4870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 8 1 0
7 11 1 0
8 9 1 0
9 10 1 0
10 1 1 0
1 11 1 0
4 12 1 0
12 13 2 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
12 14 1 0
17 20 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 272.39 | Molecular Weight (Monoisotopic): 272.1889 | AlogP: 2.60 | #Rotatable Bonds: 1 |
Polar Surface Area: 32.34 | Molecular Species: BASE | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.33 | CX LogP: 2.08 | CX LogD: -0.68 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.85 | Np Likeness Score: -0.87 |
References
1. Bavo F, de-Jong H, Petersen J, Falk-Petersen CB, Löffler R, Sparrow E, Rostrup F, Eliasen JN, Wilhelmsen KS, Barslund K, Bundgaard C, Nielsen B, Kristiansen U, Wellendorph P, Bogdanov Y, Frølund B.. (2021) Structure-Activity Studies of 3,9-Diazaspiro[5.5]undecane-Based γ-Aminobutyric Acid Type A Receptor Antagonists with Immunomodulatory Effect., 64 (24.0): [PMID:34908407] [10.1021/acs.jmedchem.1c00290] |